Cargando…

Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy

The field of biomedical research has recently been interested in nanoplatforms with various functionalities, such as cancer drug carriers and MRI and optical imaging, as well as thermal treatment, among other things. As a result of the present investigation, a unique multifunctional liposome (MFL) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ning, Wu, Yibin, Xu, Weiqi, Li, Zhenjian, Wang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845112/
https://www.ncbi.nlm.nih.gov/pubmed/35147065
http://dx.doi.org/10.1080/10717544.2021.2008056
_version_ 1784651602574966784
author Zhang, Ning
Wu, Yibin
Xu, Weiqi
Li, Zhenjian
Wang, Lu
author_facet Zhang, Ning
Wu, Yibin
Xu, Weiqi
Li, Zhenjian
Wang, Lu
author_sort Zhang, Ning
collection PubMed
description The field of biomedical research has recently been interested in nanoplatforms with various functionalities, such as cancer drug carriers and MRI and optical imaging, as well as thermal treatment, among other things. As a result of the present investigation, a unique multifunctional liposome (MFL) was established in this investigation. Using radiofrequency-induced imaging and drug release based on magnetic field impact, a dual drug delivery targeted with tumor multi-mechanism treatment was made more effective. The C60 (fullerene) surface was coated with iron nanocomposites to establish the proposed nanosystems, and PEGylation was used (Fe(3)O(4)-C60-PEG(2000)). For fullerene radiofrequency-triggered drug release, thermosensitive DPPC liposomes with folate-DSPE-PEG(2000) enveloped the binary nanosystems and doxorubicin (DOX). The in vitro cytotoxicity of the nanocomposites was confirmed by the liver metastasis in HT-29 colon cancer cells using radiofrequency. The flow cytometry analysis confirmed the apoptosis cell death mechanism. The thermal treatment combined chemotherapeutic MFL nano framework transformed radiofrequency radiation from thermoresponsive liposomes, which was noticed both in vivo and in vitro. Due to their superior active tumor targeting and magnetic targeting characteristics, the MFL could also selectively destroy cancerous liver cells in highly co-localized targets.
format Online
Article
Text
id pubmed-8845112
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88451122022-02-16 Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy Zhang, Ning Wu, Yibin Xu, Weiqi Li, Zhenjian Wang, Lu Drug Deliv Research Article The field of biomedical research has recently been interested in nanoplatforms with various functionalities, such as cancer drug carriers and MRI and optical imaging, as well as thermal treatment, among other things. As a result of the present investigation, a unique multifunctional liposome (MFL) was established in this investigation. Using radiofrequency-induced imaging and drug release based on magnetic field impact, a dual drug delivery targeted with tumor multi-mechanism treatment was made more effective. The C60 (fullerene) surface was coated with iron nanocomposites to establish the proposed nanosystems, and PEGylation was used (Fe(3)O(4)-C60-PEG(2000)). For fullerene radiofrequency-triggered drug release, thermosensitive DPPC liposomes with folate-DSPE-PEG(2000) enveloped the binary nanosystems and doxorubicin (DOX). The in vitro cytotoxicity of the nanocomposites was confirmed by the liver metastasis in HT-29 colon cancer cells using radiofrequency. The flow cytometry analysis confirmed the apoptosis cell death mechanism. The thermal treatment combined chemotherapeutic MFL nano framework transformed radiofrequency radiation from thermoresponsive liposomes, which was noticed both in vivo and in vitro. Due to their superior active tumor targeting and magnetic targeting characteristics, the MFL could also selectively destroy cancerous liver cells in highly co-localized targets. Taylor & Francis 2022-02-11 /pmc/articles/PMC8845112/ /pubmed/35147065 http://dx.doi.org/10.1080/10717544.2021.2008056 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhang, Ning
Wu, Yibin
Xu, Weiqi
Li, Zhenjian
Wang, Lu
Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy
title Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy
title_full Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy
title_fullStr Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy
title_full_unstemmed Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy
title_short Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy
title_sort synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845112/
https://www.ncbi.nlm.nih.gov/pubmed/35147065
http://dx.doi.org/10.1080/10717544.2021.2008056
work_keys_str_mv AT zhangning synergicfabricationofmultifunctionalliposomesnanocompositesforimprovedradiofrequencyablationcombinationforlivermetastasiscancertherapy
AT wuyibin synergicfabricationofmultifunctionalliposomesnanocompositesforimprovedradiofrequencyablationcombinationforlivermetastasiscancertherapy
AT xuweiqi synergicfabricationofmultifunctionalliposomesnanocompositesforimprovedradiofrequencyablationcombinationforlivermetastasiscancertherapy
AT lizhenjian synergicfabricationofmultifunctionalliposomesnanocompositesforimprovedradiofrequencyablationcombinationforlivermetastasiscancertherapy
AT wanglu synergicfabricationofmultifunctionalliposomesnanocompositesforimprovedradiofrequencyablationcombinationforlivermetastasiscancertherapy